Browse Pet Safety Reports
143,870 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 143,870 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 143,870 FDA veterinary adverse event reports for Cat.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Mar 6, 2025 | Cat | Cat (other) | Cefovecin | Respiratory tract disorder NOS; Death | Died |
| Mar 6, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Pruritus; Skin scab | Ongoing |
| Mar 6, 2025 | Cat | Persian | Selamectin;Sarolaner | Bruising; Low platelet count; Anaemia NOS; Elevated alanine aminotransferase ... | Ongoing |
| Mar 6, 2025 | Cat | American Curl Shorthair | Frunevetmab | Lack of efficacy - NOS; Local swelling (not application site); Localised pain... | Ongoing |
| Mar 6, 2025 | Cat | Domestic Shorthair | Frunevetmab | Pruritus; Skin scab | Ongoing |
| Mar 6, 2025 | Cat | Cat (other) | Frunevetmab | Lameness; Hypophosphataemia; Hypokalaemia; Bone and joint disorder NOS | Ongoing |
| Mar 5, 2025 | Cat | Maine Coon | Robenacoxib | Pain NOS; Lameness; Not eating; Fever; High pancreatic-specific lipase; Letha... | Recovered/Normal |
| Mar 5, 2025 | Cat | Cat (unknown) | Fluralaner Spot-On Solution | Itching; Self trauma; Hair loss NOS | Ongoing |
| Mar 5, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Elevated symmetrical dimethylarginine (SDMA); Hypercalcaemia; Hyperkalaemia; ... | Outcome Unknown |
| Mar 5, 2025 | Cat | Domestic Shorthair | Meloxicam | Anorexia; Abnormal radiograph finding | Ongoing |
| Mar 5, 2025 | Cat | Domestic Longhair | Frunevetmab | Anaphylaxis; Bloody diarrhoea; Vomiting; Crying; Pain NOS; Breathing difficul... | Ongoing |
| Mar 5, 2025 | Cat | Siamese | Frunevetmab | Hypercalcaemia; Elevated cholesterol (total); High pancreatic-specific lipase... | Ongoing |
| Mar 5, 2025 | Cat | Domestic Shorthair | Nitenpyram | Panting; Vocalisation; Trembling; Skin warmth; Agitation; Scratching; Abnorma... | Outcome Unknown |
| Mar 5, 2025 | Cat | Domestic Shorthair | Praziquantel; Emodepside | Heavy breathing; Emesis (multiple) | Recovered/Normal |
| Mar 5, 2025 | Cat | Domestic Shorthair | Nitenpyram | Scratching | Recovered/Normal |
| Mar 5, 2025 | Cat | Domestic Shorthair | Frunevetmab | Alopecia; Pruritus; Dermatitis | Ongoing |
| Mar 5, 2025 | Cat | Cat (unknown) | Capromorelin | Wobbliness | Outcome Unknown |
| Mar 5, 2025 | Cat | Domestic Longhair | Velagliflozin Proline Monohydrate | Elevated alanine aminotransferase (ALT); Elevated blood urea nitrogen (BUN); ... | Outcome Unknown |
| Mar 5, 2025 | Cat | British cat | Fluralaner Spot-On Solution | Itching; Self trauma; Hair loss NOS | Ongoing |
| Mar 5, 2025 | Cat | Domestic Shorthair | Fluralaner/Moxidectin Spot-On | Licking at application site; Application site hair loss | Ongoing |
| Mar 5, 2025 | Cat | Domestic Mediumhair | Velagliflozin Proline Monohydrate | Ketosis | Outcome Unknown |
| Mar 5, 2025 | Cat | Domestic (unspecified) | Robenacoxib | Malaise; Obtunded; Dehydration; Acute renal failure; Elevated blood urea nitr... | Euthanized |
| Mar 5, 2025 | Cat | Sphynx | Frunevetmab | Balance impaired; Lameness; Difficulty standing; Hiding; Elevated symmetrical... | Ongoing |
| Mar 5, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Application site scratching; Application site hair loss; Application site inf... | Ongoing |
| Mar 5, 2025 | Cat | Domestic Shorthair | Pyrantel Pamoate (Pyrantel Embonate) | Licking at application site; Application site hair loss | Recovered/Normal |
| Mar 5, 2025 | Cat | Domestic Shorthair | Buprenorphine | Panting; Hyperthermia; Agitation | Ongoing |
| Mar 5, 2025 | Cat | Cat (other) | Frunevetmab | Lack of efficacy - NOS | Outcome Unknown |
| Mar 5, 2025 | Cat | Domestic Shorthair | Buprenorphine | Sedation; Hyperthermia; Sneezing | Recovered/Normal |
| Mar 5, 2025 | Cat | Domestic Shorthair | Buprenorphine | Application site alopecia; Underdose | Ongoing |
| Mar 5, 2025 | Cat | Domestic Shorthair | Cefovecin | Death; Intentional misuse | Died |
| Mar 5, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Application site erythema; Application site alopecia; Application site scab | Ongoing |
| Mar 5, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Elevated alanine aminotransferase (ALT); Elevated aspartate aminotransferase ... | Ongoing |
| Mar 5, 2025 | Cat | Domestic Shorthair | Fluralaner Spot-On Solution | Unable to walk; Horner's syndrome; Tremor | Ongoing |
| Mar 5, 2025 | Cat | Domestic Shorthair | Frunevetmab | General illness | Ongoing |
| Mar 5, 2025 | Cat | Domestic Shorthair | Molidustat Sodium | Weight loss; Decreased haematocrit | Outcome Unknown |
| Mar 5, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Vomiting; Ketonuria; Decreased appetite; Hypoglycaemia | Outcome Unknown |
| Mar 5, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Lack of efficacy - NOS | Outcome Unknown |
| Mar 5, 2025 | Cat | Rex - Devon | Cefovecin | Unwell; Sleepiness - systemic disorder; Not himself/herself; Limb weakness; E... | Ongoing |
| Mar 5, 2025 | Cat | Cat (unknown) | Bexagliflozin | Lack of efficacy - NOS | Outcome Unknown |
| Mar 5, 2025 | Cat | Maine Coon | Frunevetmab | Diarrhoea; Weight loss | Outcome Unknown |
| Mar 5, 2025 | Cat | Domestic Shorthair | Amoxicillin Trihydrate;Clavulanate Po... | Hot spot (pyotraumatic dermatitis); Walking difficulty; Hind limb paresis; Ga... | Recovered/Normal |
| Mar 5, 2025 | Cat | Cat (unknown) | Praziquantel | Lack of efficacy (endoparasite) - tapeworm | Outcome Unknown |
| Mar 5, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Death | Died |
| Mar 5, 2025 | Cat | Maine Coon | Velagliflozin Proline Monohydrate | Diarrhoea; Weight loss | Outcome Unknown |
| Mar 5, 2025 | Cat | Domestic Shorthair | Cefovecin | Death | Died |
| Mar 5, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Weight loss; Proteinuria; Abnormal radiograph finding | Outcome Unknown |
| Mar 5, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Weight loss | Outcome Unknown |
| Mar 5, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Application site hair loss | Recovered/Normal |
| Mar 5, 2025 | Cat | Domestic Shorthair | Insulin Injectable Vial | Lack of efficacy - NOS | Ongoing |
| Mar 5, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Application site alopecia; Application site pruritus; Application site erythema | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.